Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Neisseria gonorrhoeae | Dihydrofolate reductase | Starlite/ChEMBL | References |
Escherichia coli | Dihydrofolate reductase | Starlite/ChEMBL | References |
Plasmodium berghei | bifunctional dihydrofolate reductase-thymidylate synthase, putative | Starlite/ChEMBL | References |
Rattus norvegicus | Dihydrofolate reductase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0421 | 0.7592 | 1 |
Brugia malayi | hypothetical protein | 0.0062 | 0.0764 | 0.0764 |
Echinococcus granulosus | dihydrofolate reductase | 0.0547 | 1 | 1 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0041 | 0.0374 | 0.4887 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.014 | 0.2253 | 0.2253 |
Trypanosoma brucei | RNA helicase, putative | 0.0081 | 0.1126 | 0.1483 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0023 | 0.0035 | 0.0046 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0421 | 0.7592 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0081 | 0.1126 | 0.1126 |
Onchocerca volvulus | 0.013 | 0.2058 | 1 | |
Echinococcus multilocularis | dihydrofolate reductase | 0.0547 | 1 | 1 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0022 | 0 | 0.5 |
Brugia malayi | thymidylate synthase | 0.013 | 0.2058 | 0.2058 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.013 | 0.2058 | 0.1401 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0041 | 0.0374 | 0.0492 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0547 | 1 | 1 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0421 | 0.7592 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.0547 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0022 | 0 | 0.5 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0421 | 0.7592 | 1 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0547 | 1 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0041 | 0.0374 | 0.0492 |
Loa Loa (eye worm) | acetyltransferase | 0.014 | 0.2253 | 0.0246 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0421 | 0.7592 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0023 | 0.0035 | 0.0046 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0023 | 0.0035 | 0.0046 |
Echinococcus multilocularis | thymidylate synthase | 0.013 | 0.2058 | 0.2058 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0038 | 0.0308 | 0.5 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0547 | 1 | 0.5 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0547 | 1 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.014 | 0.2253 | 0.2253 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0038 | 0.0308 | 1 |
Brugia malayi | Dihydrofolate reductase | 0.0547 | 1 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.013 | 0.2058 | 0.2058 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0136 | 0.2179 | 0.2179 |
Echinococcus granulosus | thymidylate synthase | 0.013 | 0.2058 | 0.2058 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0062 | 0.0764 | 1 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0023 | 0.0035 | 0.0046 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0547 | 1 | 1 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0041 | 0.0374 | 0.0374 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.014 | 0.2253 | 0.2253 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0421 | 0.7592 | 1 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.0035 | 0.0046 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0041 | 0.0374 | 0.4887 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0062 | 0.0764 | 0.1007 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
I50 (binding) | = 58000000 M | Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei | ChEMBL. | 3100802 |
I50 (binding) | = 170000000 M | Inhibitory activity against dihydrofolate reductase (DHFR) from Escherichia coli | ChEMBL. | 3100802 |
I50 (binding) | = 1320000000 M | Inhibitory activity against dihydrofolate reductase (DHFR) of Neisseria gonorrhoea | ChEMBL. | 3100802 |
I50 (binding) | = 150000000000 M | Inhibitory activity against dihydrofolate reductase (DHFR) from rat liver | ChEMBL. | 3100802 |
IC50 (binding) | = 0.0000000058 M | Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei | ChEMBL. | 3100802 |
IC50 (binding) | = 0.000000017 M | Inhibitory activity against dihydrofolate reductase (DHFR) from Escherichia coli | ChEMBL. | 3100802 |
IC50 (binding) | = 0.000000132 M | Inhibitory activity against dihydrofolate reductase (DHFR) of Neisseria gonorrhoea | ChEMBL. | 3100802 |
IC50 (binding) | = 0.000015 M | Inhibitory activity against dihydrofolate reductase (DHFR) from rat liver | ChEMBL. | 3100802 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.